check quantity

IVISense Vascular 680 Fluorescent Probe (AngioSense)

In vivo optical imaging of vascular changes and vascular leak is an emerging modality for studying altered physiology in a variety of different cancers and inflammatory states. In oncology, increases in tumor vascular permeability can be an early indicator of tumor angiogenesis. In inflammatory disease increased vascular permeability can indicate alterations in fluid homeostasis in an acute edema response or in chronic organ conditions.

PerkinElmer’s IVISense Vascular NIR fluorescent probes (AngioSense®) are designed to evaluate vascular changes to better understand various disease states or provide valuable information on the effects of drug candidates earlier in the development process.

For research use only. Not for use in diagnostic procedures.


Part Number
SKU Display Name
List Price
Your Price
IVISense Vascular 680 Fluorescent Probe (AngioSense)
716.00 USD
IVISense Vascular 750 Fluorescent Probe (AngioSense)
717.00 USD
Buy Now

Please enter valid quantity

Please log in to add favorites.



IVISense Vascular 680 fluorescent imaging probe (AngioSense 680EX) is an in vivo blood pool vascular agent that remains localized in the vasculature for extended periods of time (0-4 hrs) enabling imaging of vascularity, perfusion, and vascular permeability at a wavelength of 680 nm. The probe accumulates in tumors and arthritic joints at 24 hrs. IVISense Vascular 680 fluorescent agent can be used as a single probe or multiplexed with probes at other wavelengths.


Fluorescent Agent Type Vascular
Optical Imaging Classification Fluorescence Imaging
Product Brand Name IVISense
Quantity in a Package Amount 1.0 Units
Shipping Condition Blue Ice
Therapeutic Area Vascular disease, Angiogenesis, Arthritis, Inflammation, Oncology/Cancer
Unit Size 1 Vial (10 doses)
Wave Length 680 nm
Resources, Events & More
  • All

Application Note

Vascular Imaging Probes For Oncology and Inflammation Using the IVIS Spectrum

Optical-based in vivo imaging of vascular changes and vascular leak is an emerging modality for studying altered physiology in a variety of different cancers and inflammatory states. A number of fluorescent imaging probes that circulate with the blood, but have no target selectivity, have been used ...



In Vivo Imaging Solutions eBook

Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and therapeutic efficacies for a broad range of indications. Our reagents, instruments, and applications support have helped hundreds of research projects over the years. And ...



Best Practices for Designing An Effective In Vivo Fluorescence Imaging Study

Fluorescence molecular imaging is the visualization of cellular and biological function in vivo to gain deeper insights into disease processes and treatment effects. Designing an effective study from the beginning can help save time and resources.

Learn about several important best p ...

PDF 507 KB


IVISense™ Fluorescent Probe Selector Guide for Oncology Research

The goal of in vivo fluorescence molecular imaging is to enable non-invasive visualization and quantification of cellular and biological functioning to better understand and characterize disease processes and treatment effects earlier within the context of a biological system.

This s ...



Combined efficacy & toxicity imaging following acute 5-FU treatment of HT-29 tumor xenografts

Cancer chemotherapy can produce severe side effects such as suppression of immune function and damage to heart muscle, gastrointestinal tract, and liver. If serious enough, tissue injury can be a major reason for late stage termination of drug discovery research projects, so it is becoming more impo ...


Technical Note

AngioSense 680EX (Protocol)

AngioSense 680 EX in vivo imaging agent protocol for preparing mice for imaging, preparing AngioSense 680EX agent, injections of agent into mice, imaging injected mice on IVIS and FMT imaging systems


White Paper

The Role of In Vivo Imaging in Drug Discovery and Development

The primary goal of preclinical imaging is to improve the odds of clinical success and reduce drug discovery and development time and costs. Advances in non-invasive in vivo imaging techniques have raised the use of animal models in drug discovery and development to a new level by enabling quick ...

PDF 547 KB